文献速递疼痛医学区域麻醉与超声

高渗盐水浓度对硬膜外粘连松解术疗效与安全性的回顾性研究

A Retrospective Study to Evaluate the Effect of Concentration of Hypertonic Saline on Efficacy and Safety of Epidural Adhesiolysis.
PubMed 文献 · Anesth Analg · 2017-01-01

该回顾性研究纳入543例接受腰椎经皮硬膜外粘连松解术(PEA)的患者,比较5%与10%高渗盐水的疗效与安全性。两组术后6个月疼痛评分均较基线显著降低,但组间无显著差异;结论提示5%高渗盐水可作为10%的替代选择。

要点

  • 5%与10%高渗盐水在PEA术后6个月疼痛缓解方面无显著差异。
  • 5%高渗盐水可考虑作为腰椎PEA中10%高渗盐水的替代浓度。

核心结论

  • 在腰椎PEA中,5%高渗盐水随访6个月后的疗效与10%高渗盐水相似,且输注相关疼痛更少。
  • 结果提示5%高渗盐水可作为10%高渗盐水的替代选择用于腰椎PEA。

研究设计与样本

  • 回顾性研究,纳入2009年1月至2014年6月在韩国两家大型民用教学医院接受腰椎PEA的患者543例(5%组333例,10%组210例)。
  • 根据盐水渗透压将患者分配至5%或10%高渗盐水组。
  • 主要结局为基线至PEA后6个月11点数字评分量表(NRS)腰腿痛评分变化在两组间的差异。

主要发现

  • 两组PEA后NRS疼痛评分均较基线显著降低。
  • 除输注相关疼痛外,两组在PEA后6个月或任何时间点的临床特征均无显著差异。
  • 多变量线性回归分析(调整协变量包括追加硬膜外注射次数)显示患者分组与6个月随访NRS疼痛评分下降无显著关联。
  • 3例患者记录到PEA相关的短暂不良事件(10%组2例,5%组1例)。

临床怎么用

  • 腰椎PEA中可考虑使用5%高渗盐水替代10%高渗盐水,以降低输注相关疼痛。
  • 需进一步前瞻性随机研究来更好地评估不同浓度高渗盐水用于PEA的结局。

局限性

  • 本研究为回顾性研究。
  • 需要进一步前瞻性随机研究来验证不同浓度高渗盐水用于PEA的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Percutaneous epidural adhesiolysis (PEA) is a minimally invasive procedure that is performed to relieve low back and/or lower limb pain secondary to adhesions or scarring in the epidural space that is refractory to conservative treatment. The optimal concentration of hypertonic saline might be an important factor in the safety and efficacy of PEA. We evaluated differences in the efficacy and safety of 2 concentrations of hypertonic saline (5% and 10%) used in lumbar PEA at our institutions in a retrospective study. METHODS: Patients who received lumbar PEA between January 2009 and June 2014 at either of 2 large civilian teaching institutions in South Korea were assigned to the 5% or 10% groups according to the osmolality of saline. The primary outcome of this study was the difference in change in the 11-point numerical rating scale (NRS) scores of low back and leg pain from baseline to 6 months after PEA between patients in the 2 groups. The number of additional epidural injections, patients' satisfaction with PEA, and any complications that occurred within 6 months after PEA were reviewed. RESULTS: This study included 543 patients (5% group, 333; 10% group, 210). Post-PEA NRS pain scores were significantly lower compared with those at baseline in both groups; however, there were no significant differences between the 2 groups at 6 months or any time point after PEA with regard to any of the clinical characteristics, except infusion-related pain, which exhibited borderline significance for greater scores in the 10% group compared with those in the 5% group (P = .041). Multivariable linear regression analysis with adjustments for covariates, including the number of additional epidural injections, revealed no significant association between patient group and the decrease in NRS pain scores at 6 months of follow-up. Transient adverse events related to PEA were recorded in 3 patients (10% group, 2; 5% group, 1). CONCLUSIONS: In PEA, 5% hypertonic saline exhibited similar positive outcomes after 6 months of follow-up as 10% hypertonic saline, with less infusion-related pain. This result suggests that infusion of 5% hypertonic saline may be considered as an alternative to 10% hypertonic saline in lumbar PEA. Further prospective randomized studies are required to better appreciate the outcome with regard to the use of different concentrations of hypertonic saline for PEA.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Choi EJ, Yoo YJ, Lee PB, et al. A Retrospective Study to Evaluate the Effect of Concentration of Hypertonic Saline on Efficacy and Safety of Epidural Adhesiolysis. Anesth Analg. 2017. PMID: 28448392. doi:10.1213/ANE.0000000000001925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。